Anand Rathi Securities is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 312 in its February 24, 2011 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!